Keryx Biopharma (KERX) Posts Q4 Loss of 44c/Share

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/26/2026

1. ORCL
2. SPY
3. ANT
4. FFAI
5. FFR
6. LLY
7. TSLA
8. META
9. FICO
10. CART

Go back to Keryx Biopharma (KERX) Posts Q4 Loss of 44c/Share

Roth Capital Trims PT on Keryx Biopharma (KERX) to $27; 'Blocking and Tacking' w/ Medicare to Ensure Auryxia Success

February 27, 2015 10:36 AM EST

Roth Capital affirms Keryx Biopharma (Nasdaq: KERX) at Buy and lowers its price target from $32 to $27 following Q4/FY14 results issued earlier Friday.

Analyst Joseph Pantginis noted that Keryx's FY14 loss of $1.23 per share compared with the firm's loss estimate of $1.18 per share. No revenue was reported for Auryxia,... More

Keryx Biopharma (KERX) Announces Departure of CFO Oliviero

February 27, 2015 7:49 AM EST

On February 27, 2015, Keryx Biopharma (NASDAQ: KERX) announced a planned consolidation of its finance and accounting function into its Boston office and that its Chief Financial Officer, James Oliviero, will be leaving Keryx by October 2015. Mr. Oliviero has been with Keryx for twelve... More